Ismail, Heba M.2023-03-212023-03-212021-10-21Ismail HM. Potential Role for the Use of Gliptins in Cystic Fibrosis-related Diabetes. J Clin Endocrinol Metab. 2021;106(11):e4786-e4788. doi:10.1210/clinem/dgab442https://hdl.handle.net/1805/31981en-USAttribution-NonCommercial-NoDerivatives 4.0 InternationalDDP-4 inhibitorAbnormal glucose toleranceCystic fibrosis-related diabetesGlucagonGlucagon-like peptide1 (GLP-1)Glucose-dependent insulinotropic polypeptideIncretinInsulinSitagliptinPotential Role for the Use of Gliptins in Cystic Fibrosis-related DiabetesArticle